Safety and Efficacy of STR001-IT and STR001-ER in Patients With SSHL

PHASE3CompletedINTERVENTIONAL

Enrollment

165

Participants

Timeline

Start Date

February 24, 2018

Primary Completion Date

February 6, 2020

Study Completion Date

February 6, 2020

Conditions

Acute Hearing Loss

Interventions

DRUG

STR001-IT and STR001-ER

STR001-IT intrataympanic injection and STR001-ER tablet

Trial Locations (3)

Universitätsspital Zürich, Zurich

Universitätsklinik Freiburg, Freiburg im Breisgau

Fakultni nemocnice Hradec Kralove, Hradec Králové

All Listed Sponsors

lead

Strekin AG

INDUSTRY

NCT03331627 - Safety and Efficacy of STR001-IT and STR001-ER in Patients With SSHL | Biotech Hunter | Biotech Hunter